NCT05280002View on ClinicalTrials.gov

Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Osteoarthritis Knees
Interventions
BIOLOGICAL

Adipose Tissue derived Total-Stromal-Cells (TOST)

Single dose autologous aAdipose Tissue derived Total-Stromal-Cells (TOST) containing mesenchymal stem cell was injected in each knee of the participants having knee osteoarthritis.

Trial Locations (1)

Unknown

Bangabandhu Sheikh Mujib Medical University, Dhaka

Sponsors

Collaborators (1)

Dhaka Medical College
All Listed Sponsors
collaborator

Dhaka Medical College

OTHER

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER